News
2h
HealthDay on MSNTexas Invests $50M in Psychedelic Drug Research to Treat AddictionKey Takeaways Texas is spending $50 million to study ibogaine, a powerful psychedelic drugThe goal is to treat opioid ...
Dr. Stephen Loyd is the chief medical officer of Cedar Recovery, president of the Tennessee Board of Medical Examiners and a ...
Dr. Bernard Fialkoff Presenting at Albany. Dr. Bernard Fialkoff Presenting at SOMOS Congress. Dr. Bernard Fialkoff Presenting for San Fernando Valley / Los ...
By Deiksha Veerapaneni Imagine being able to not feel pain and instead feel intense relief? That would be pretty addicting, right? For many, that feeling sounds like an escape, a break from suffering.
A study led by University of Manchester epidemiologists has revealed which opioid painkillers are most likely to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results